Open Orphan

Open Orphan spin-out Poolbeg Pharma to list on London market – 17 June 2021

Demerger Update on Poolbeg Pharma – 17 June 2021

Open Orphan subsidiary wins €7.5m contract to run study – 26 March 2021

Open Orphan (LON:ORPH) Presenting at the Proactive One2One Virtual Forum – 11 March 2021

Open Orphan’s Venn business wins contract to support clinical trial – 9 March 2021

What do we know about the UK trial to infect people with Covid-19? – 17 Feb 2021

Open Orphan jumps as COVID-19 study receives ethics approval – 17 Feb 2021

World’s first Covid-19 study where people are infected with virus to begin in London – Government funding of around £33m was given to the human challenge trial. – Shares in Open Ophan, which manages medical trials for a range of pharma companies and universities, are up more than seven per cent on the news. -17 Feb 2021

Medical trial firm converts East End hotel as Covid19 nasal vaccine study ramps up – 3 Feb 2021

UK taps Open Orphan to explore vaccine trials that infect volunteers with coronavirus – The characterization study is expected to be complete in 2021 and is still subject to ethical and regulatory approval. Sponsored by Imperial College in the U.K., the study will be conducted by Open Orphan’s hVivo unit at a London-based research site. – 20 Oct 2020

Cathal Friel, Executive Chair, Open Orphan speaking at London South East’s September Webinar – Sickness & Disease the number 1 investment! –  1 Oct 2020

Open Orphan to merge with UK-based Hvivo in £30m tie-up – 9 Dec 2019

this site will help you catch up if you're just waking up to some things now.